Login
$DOCS
$33.23 +$0.15 (0.45%) Live

Consolidated balance sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jun 30, 2026
Q4 FY2026
As of Mar 31, 2026
Q3 FY2026
As of Dec 31, 2025
Q2 FY2026
As of Sep 30, 2025
Q1 FY2026
As of Jun 30, 2025
Q4 FY2025
As of Mar 31, 2025
Q3 FY2025
As of Dec 31, 2024
Q2 FY2025
As of Sep 30, 2024
Q1 FY2025
As of Jun 30, 2024
Q4 FY2024
As of Mar 31, 2024
Q3 FY2024
As of Dec 31, 2023
Q2 FY2024
As of Sep 30, 2023
Q1 FY2024
As of Jun 30, 2023
Q4 FY2023
As of Mar 31, 2023
Q3 FY2023
As of Dec 31, 2022
Q2 FY2023
As of Sep 30, 2022
Q1 FY2023
As of Jun 30, 2022
Q4 FY2022
As of Mar 31, 2022
Q3 FY2022
As of Dec 31, 2021
Q2 FY2022
As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net of allowance for doubtful accounts of $1,956 and $1,345 at June 30, 2026 and March 31, 2026, respectively
Prepaid expenses and other current assets
Deferred contract costs, current
Total current assets
Property and equipment, net
Deferred income tax assets
Operating lease right-of-use assets
Intangible assets, net
Goodwill
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue, current
Operating lease liabilities, current
Total current liabilities
Deferred revenue, non-current
Operating lease liabilities, non-current
Contingent earn-out consideration liability, non-current
Income taxes payable, non-current
Other liabilities, non-current
Total liabilities
Redeemable convertible preferred stock, $0.001 par value; zero and 76,350 shares authorized as of March 31, 2022 and 2021, respectively; zero and 76,287 shares issued and outstanding as of March 31, 2022 and 2021, respectively; liquidation preference of zero and $81,672 as of March 31, 2022 and 2021, respectively
Stockholders' Equity
Preferred stock, $0.001 par value; 100,000 shares authorized as of June 30, 2026 and March 31, 2026, respectively; zero shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively
Class A and Class B common stock, $0.001 par value; 1,500,000 shares authorized as of June 30, 2026 and March 31, 2026, respectively; 179,849 and 183,060 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support